Prolia® is a prescription medicine used to increase bone mass in men with osteoporosis who are at high risk for fracture.
Prolia® is a prescription medicine used to treat osteoporosis in men and women who will be taking corticosteroid medicines (such as prednisone) for at least six months and are at high risk for fracture.
Prolia® is a prescription medicine used to treat bone loss in men who are at high risk for fracture receiving certain treatments for prostate cancer that has not spread to other parts of the body.
Prolia® is a prescription medicine used to treat bone loss in women who are at high risk for fracture receiving certain treatments for breast cancer that has not spread to other parts of the body. Read Less
For women with osteoporosis after menopause at high risk for fracture
Results from the 3-year clinical study proved that Prolia®:
You should take calcium and vitamin D as your doctor tells you to while you receive Prolia®. After your treatment with Prolia® is stopped, or if you skip or delay taking a dose, your risk for breaking bones, including bones in your spine, is increased. Do not stop, skip or delay taking Prolia® without first talking with your doctor.
For women with osteoporosis after menopause at high risk for fracture whose current osteoporosis medicine is not working well
In a 1-year study, women who switched from alendronate to Prolia® showed a significant increase in bone mineral density (BMD) at the hip and the lumbar spine compared to women who stayed on alendronate, a commonly prescribed bisphosphonate (such as Fosamax®).
This study of over 500 women with postmenopausal osteoporosis compared the bone mineral density of women who switched from alendronate to Prolia® vs women who stayed on their alendronate treatment.
This study only evaluated bone mineral density. These results do not imply fracture risk reduction.
This study only evaluated bone mineral density. These results do not imply fracture risk reduction.
In a 1-year study, Prolia® showed a significant increase in bone mineral density (BMD) at the
lumbar spine and the hip vs zoledronic acid (such as Reclast®).
This study of over 600 women with postmenopausal osteoporosis compared the bone mineral density (BMD)
of women who switched from oral bisphosphonates to Prolia® vs women who switched from oral
bisphosphonates to zoledronic acid.
This study only evaluated bone mineral density. These results do not imply fracture risk reduction.
This study only evaluated bone mineral density. These results do not imply fracture risk reduction.
Learn about Prolia® dosing
See how Prolia® dosing compares to other treatments.
Ask your doctor about Prolia®
Download a personalized discussion guide to start the conversation with your doctor.
What are the possible side effects of Prolia®?
It is not known if the use of Prolia® over a long period of time may cause slow healing of broken bones. The most common side effects of Prolia® in women being treated for osteoporosis after menopause are back pain, pain in your arms and legs, high cholesterol, muscle pain, and bladder infection.
The most common side effects of Prolia® in men with osteoporosis are back pain, joint pain, and common cold (runny nose or sore throat).
The most common side effects of Prolia® in patients with corticosteroid-induced osteoporosis are back pain, high blood pressure, lung infection (bronchitis), and headache.
The most common side effects of Prolia® in patients receiving certain treatments for prostate or breast cancer are joint pain, back pain, pain in your arms and legs, and muscle pain. Additionally, in Prolia®-treated men with nonmetastatic prostate cancer receiving ADT, a greater incidence of cataracts was observed.
These are not all the possible side effects of Prolia®. Call your doctor for medical advice about side effects.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Prolia® is a prescription medicine used to treat osteoporosis in women after menopause who are at high risk for fracture or cannot use another osteoporosis medicine or other osteoporosis medicines did not work well.
Prolia® is a prescription medicine used to increase bone mass in men with osteoporosis who are at high risk for fracture.
Prolia® is a prescription medicine used to treat osteoporosis in men and women who will be taking corticosteroid medicines (such as prednisone) for at least six months and are at high risk for fracture.
Prolia® is a prescription medicine used to treat bone loss in men who are at high risk for fracture receiving certain treatments for prostate cancer that has not spread to other parts of the body.
Prolia® is a prescription medicine used to treat bone loss in women who are at high risk for fracture receiving certain treatments for breast cancer that has not spread to other parts of the body.
Please see Prolia® full Prescribing Information and Medication Guide.